Watts Ryan J. 4
4 · Denali Therapeutics Inc. · Filed Aug 22, 2024
Insider Transaction Report
Form 4
Watts Ryan J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-08-20$23.79/sh−2,260$53,765→ 235,807 total
Holdings
- 2,202,604(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
- [F2]Includes 197,200 Unvested RSUs.
- [F3]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.